InterCure

InterCure Rule of 40

The Rule of 40 of InterCure (INCR.TA) as of Oct 22, 2026 is -53.46 %. In the previous year, Rule of 40 was 0.39 % — a change of -13,774.53% (lower).

Rule of 40

-53.46 %

YoY

-13,774.53%

Last updated:

Rule of 40 of InterCure is 2024 -53.46 % . Rule of 40 of InterCure was 2023 0.39 % . It decreases by -13,774.53% lower compared to the previous year.

The InterCure Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2020
567.11 ILS
Jan 1, 2021
255.76 ILS
Jan 1, 2022
93.25 ILS
Jan 1, 2023
0.39 ILS
Jan 1, 2024
-53.46 ILS
The InterCure Rule of 40 history
YEARRule of 40YoY
-53.46 %-13,774.53%
0.39 %-99.58%
93.25 %-63.54%
255.76 %-54.90%
567.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

InterCure Stock analysis

What does InterCure do? InterCure Ltd. is a global company in the medical technology industry that focuses on the development, production, and distribution of innovative solutions for the diagnosis and treatment of chronic diseases. The company was founded in Israel in 2000 and is headquartered in Lod. InterCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InterCure stock

Rule of 40 of InterCure is -53.46 % in 2024.

On Eulerpool you can find the complete historical development of Rule of 40 InterCure since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — InterCure

All Key Metrics — InterCure